Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7299 p600
15 May 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Consultation letter (PDF 230K)
Feedback (more)

The Prescription Only Medicines (Human Use) Amendment (more)
The Medicines (Pharmacy and General sale — Exemption) Amendment (more)


Supplementary prescribing to be extended next year

Chiropodists, physiotherapists, radiographers and optometrists are to be the next professionals to join the ranks of supplementary prescribers. The planned legislative change will apply throughout the UK, but it is for the devolved administrations to determine the extent of its local application in the NHS.

Consultation on proposals to allow members of these groups to start supplementary prescribing from early in 2005 started on 10 May and will continue for 12 weeks.

Although the consultation contains no proposals on the extent of the responsibility for these new prescribers, the Department of Health says that they would encompass the treatment and management of conditions such as glaucoma, chronic back pain and the effects of multiple sclerosis, as well as providing pain relief for patients attending radiography sessions.

Supplementary prescribing is a voluntary partnership between a doctor or dentist and another health professional to prescribe medicines under agreed patient-specific clinical management plans. It is not restricted to the NHS. Currently, supplementary prescribers cannot prescribe Controlled Drugs, but this is expected to become possible later this year.

Dietitians, occupational therapists, orthotists, prosthetists, and speech and language therapists will be allowed to supply and administer prescription medicines under patient group directions from 18 May (PJ, 9 August 2003, p166). Chiropodists, physiotherapists, radiographers and optometrists are already allowed to sell, supply or administer medicines under patient group directions.

Back to Top


©The Pharmaceutical Journal